Abstract Combined asparaginase-based chemoradiotherapy is effective for early-stage extranodal natural killer/T-cell lymphoma (NKTCL), but haematologic toxicity and infection can compromise treatment delivery. We evaluated a chemotherapy-sparing induction regimen of camrelizumab, low-dose apatinib, and pegaspargase (CAPA) followed by sequential radiotherapy.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jiangbo
Contact Jiangbo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack